Different proteins have been investigated as biomarkers for cognitive decline in dementing disorders, namely, cerebrospinal fluid (CSF) Aβ-42 protein (Aβ42), total tau (t-tau), and p-tau, which are well established in the diagnosis of AD [185]. Here, MAPT is linked to Alzheimer disease.